Raise awareness this May for bladder cancer, its symptoms, and the importance of early detection to save lives.
Combat Medical (Combat), a medical device company optimising the delivery and efficacy of cancer therapeutics, today ...
AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...
Investigators sought to determine whether adjuvant radiotherapy improved locoregional control following chemotherapy and radical cystectomy for patients with high-risk muscle-invasive bladder cancer.
EU CHMP recommends approval of Merck’s Keytruda plus Padcev as perioperative treatment for adults with cisplatin-ineligible resectable muscle-invasive bladder cancer: Rahway, Ne ...
A Dorset couple say they have got no option but to consider selling their home to pay for life-extending cancer treatment ...
Daily Mail on MSN
Husband and wife both had sore backs and blamed 'kidney stones'. Turns out they had the same cancer
A couple has told how they both suffered pain most Aussies get from time to time before being diagnosed with the same cancer ...
Dr. Peter O'Donnell presented patient-reported outcomes (PROs) from the phase III KEYNOTE-905/EV-303 trial evaluating perioperative enfortumab vedotin (EV) plus pembrolizumab in cisplatin-ineligible ...
The FDA is reviewing an sBLA for nogapendekin alfa inbakicept-pmln plus BCG to treat BCG-unresponsive NMIBC with papillary disease without CIS.
Junshi Biosciences announces primary endpoints in final analysis of phase 3 study for perioperative toripalimab plus chemotherapy to treat resectable stage II-III NSCLC: Shanghai ...
Fragmented subspecialty care and underbuilt survivorship pathways risk overwhelming primary care as the survivor population ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results